59 related articles for article (PubMed ID: 24652203)
1. Therapeutic and Toxic Effects of Valproic Acid Metabolites.
Shnayder NA; Grechkina VV; Khasanova AK; Bochanova EN; Dontceva EA; Petrova MM; Asadullin AR; Shipulin GA; Altynbekov KS; Al-Zamil M; Nasyrova RF
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677060
[TBL] [Abstract][Full Text] [Related]
2. From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer.
Pellegrino M; Ricci E; Ceraldi R; Nigro A; Bonofiglio D; Lanzino M; Morelli C
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139561
[TBL] [Abstract][Full Text] [Related]
3. Whole Exome Sequencing Identifies Novel De Novo Variants Interacting with Six Gene Networks in Autism Spectrum Disorder.
Kim N; Kim KH; Lim WJ; Kim J; Kim SA; Yoo HJ
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374967
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity.
Serinan E; Altun Z; Aktaş S; Çeçen E; Olgun N
J Int Adv Otol; 2018 Aug; 14(2):211-215. PubMed ID: 29460824
[TBL] [Abstract][Full Text] [Related]
5. The pharmacogenomics of valproic acid.
Zhu MM; Li HL; Shi LH; Chen XP; Luo J; Zhang ZL
J Hum Genet; 2017 Dec; 62(12):1009-1014. PubMed ID: 28878340
[TBL] [Abstract][Full Text] [Related]
6. Isobolographic analysis demonstrates additive effect of cisplatin and HDIs combined treatment augmenting their anti-cancer activity in lung cancer cell lines.
Gumbarewicz E; Luszczki JJ; Wawruszak A; Dmoszynska-Graniczka M; Grabarska AJ; Jarząb AM; Polberg K; Stepulak A
Am J Cancer Res; 2016; 6(12):2831-2845. PubMed ID: 28042503
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells.
Çıtışlı V; Dodurga Y; Eroğlu C; Seçme M; Avcı ÇB; Şatıroğlu-Tufan NL
Tumour Biol; 2015 Sep; 36(9):6765-72. PubMed ID: 25835972
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the effects of a sulfite molecule on human neuroblastoma cells via a novel oncogene URG4/URGCP.
Dodurga Y; Seçme M; Eroğlu C; Gündoğdu G; Avcı ÇB; Bağcı G; Küçükatay V; Lale Şatıroğlu-Tufan N
Life Sci; 2015 Dec; 143():27-34. PubMed ID: 26506573
[TBL] [Abstract][Full Text] [Related]
10. A novel oncogene URG4/URGCP and its role in cancer.
Dodurga Y; Seçme M; Lale Şatıroğlu-Tufan N
Gene; 2018 Aug; 668():12-17. PubMed ID: 29775749
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid, a molecular lead to multiple regulatory pathways.
Kostrouchová M; Kostrouch Z; Kostrouchová M
Folia Biol (Praha); 2007; 53(2):37-49. PubMed ID: 17448293
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.
Dodurga Y; Gundogdu G; Tekin V; Koc T; Satiroglu-Tufan NL; Bagci G; Kucukatay V
Mol Biol Rep; 2014 Jul; 41(7):4595-9. PubMed ID: 24652203
[TBL] [Abstract][Full Text] [Related]
13. Expression of URG4/URGCP, Cyclin D1, Bcl-2, and Bax genes in retinoic acid treated SH-SY5Y human neuroblastoma cells.
Dodurga Y; Gundogdu G; Koc T; Yonguc GN; Kucukatay V; Satiroglu-Tufan NL
Contemp Oncol (Pozn); 2013; 17(4):346-9. PubMed ID: 24592121
[TBL] [Abstract][Full Text] [Related]
14. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
